FEROSE TABLETS & SYRUP For Iron Deficiencies     COMPOSITION Each chewable tablet contains 100 mg Iron as Ferric hydroxide-polymaltose complex. Each teaspoonful (5ml) syrup contains 50mg of Iron as Ferric hydroxide-polymaltose complex.     PROPERTIES Iron polymaltose as present in Ferose tablets and syrup provides an ideal preparation for all iron deficiency anemias. It is rapidly absorbed, with a high rate of iron utilization and produces an effective increase in Haemoglobin. Due to its favourable non-ionic nature it has the following properties unlike ionised iron salt preparations: - Ferose does not give rise to irritation of the intestinal mucosa and does not stain the teeth. - Ferose has palatable, non metallic taste (Ferose chewable tablets have chocolate flavour and are acceptable even by the most resistant patients of all ages). - Ferose has excellent tolerance.     INDICATIONS Prevention and treatment of all kinds of iron deficiencies, particularly iron deficiency anemia.     DOSASE & ADMINISTRATION Adults and children over 12 years : tablets : in normal cases 1 tablet daily chewed or swallowed with some liquid during or after meals. If required the dosage is increased to 1 tablet twice daily, as per physician's prescription. Syrup : 2 teaspoonful 1 - 2 times daily during or after meals. Children under 12 years : Syrup : 1 teaspoonful 1 - 2 times daily during or after meals. Infants : Begin with 1/2 of a teaspoonful daily and increase to 1 teaspoonful daily. Ferose Syrup may be mixed with fruits or vegetable juices or other liquid if desired.     CONTRAINDICATIONS - Disturbances in iron utilization (lead anemia), Thalassemia. - Hypersensitivity or intolerance to iron and overloading of iron in the body. - Anemia not caused by iron deficiency.     PRECAUTIONS As with all iron preparations, a dark colouration of the stool may occur which is without clinical significance.     PREGNANCY AND LACTATION Reproduction studies in animals did not show any foetal risk. Controlled studies in pregnant women after the first trimester have not shown any undesirable effects on mother and neonates. There is no evidence of a risk during the first trimester and the possibility of a negative influence to the foetus is unlikely to occur. Mother's milk contains iron bound to lactoferrin. It is not known how much iron from the complex is passed into mother's milk. The administration of Ferose¨ is unlikely to cause undesirable effects to the nursed child.     UNDESIRABLE EFFECTS Occasionally gastrointestinal irritations such as sensation of repletion, pressure in the epigastric region, nausea, constipation or diarrhoea can occur.     INTEREACTIONS There is no interaction between Ferose and food or between Ferose and drugs due to its non ionic nature.     PRESENTATIONS Ferose is available as tablets, syrup and Drops.